A BSA complex with palmitic acid
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BSA-Palmitate Saturated Fatty Acid Complex (1.67 mM)

Item No. 43443

Technical Information
Synonyms
  • Bovine Serum Albumin-PA
  • Bovine Serum Albumin-Palmitate
  • BSA-Hexadecanoic Acid
  • BSA-PA
Source
Bovine
1.67 mM Palmitate:0.8 mM BSA (2:1 palmitate:BSA) in 150 mM sodium chloride, pH 7.4
Origin
Animal/Bovine
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    BSA-Palmitate Saturated Fatty Acid Complex (1.67 mM) is composed of palmitic acid (Item Nos. 10006627 | 43561) and fatty acid-free bovine serum albumin (BSA) at an approximately 2:1 molar ratio of palmitate:BSA. It can be used for efficient fatty acid delivery to cells in culture for the purpose of monitoring fatty acid oxidation, lipid metabolism, and inflammatory signaling pathways, including in studies of obesity-related inflammation and insulin resistance.1,2,3 It can also be used to study the effect of long-chain fatty acid uptake on gene and protein expression, lipid droplet formation, hepatocyte lipid accumulation, and oxidative stress.4,5,6 Cayman’s BSA-Palmitate Saturated Fatty Acid Complex (1.67 mM) is suitable for use in short-term cell culture applications (acute treatment to 18 hours); however, for long-term applications (25+ hours) the product should be filter-sterilized using a 0.2 µm filter and sterile receptacle, which will not affect its performance. When used at the same lipid concentration as BSA-Palmitate Saturated Fatty Acid Complex (5 mM) (Item No. 29558) or BSA-Palmitate Saturated Fatty Acid Complex (10 mM) (Item No. 44156), which have a 6:1 molar ratio of palmitate:BSA, this product provides a lower free palmitate concentration, which may reduce the likelihood of acute lipotoxicity.7 For best results, it is recommended that this product be used in conjunction with Cayman’s BSA Control for BSA-Fatty Acid Complexes (5 mM) (Item No. 29556), prepared with fatty acid-free BSA.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Alsabeeh, N., Chausse, B., Kakimoto, P.A., et alCell culture models of fatty acid overload: Problems and solutions. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863(2), 143-151 (2018).

    2. Wang, D., Green, M.F., McDonnell, E., et alOxygen flux analysis to understand the biological function of sirtuins. Methods Mol. Biol. 1077, 241-258 (2013).

    3. Radin, M.S., Sinha, S., Bhatt, B.A., et alInhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51(2), 336-346 (2008).

    4. Muthusamy, G., Liu, C.-C., and Johnston, A.N. Deletion of PGAM5 downregulates FABP1 and attenuates long-chain fatty acid uptake in hepatocellular carcinoma. Cancers (Basel) 15(19), 4796 (2023).

    5. Das, S., Finney, A.C., Anand, S.K., et alInhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis. Nat. Metab. 6(10), 1939-1962 (2024).

    6. Guilfoyle-Speese, A., Patel, K., Ghanwat, A.H., et alShort-chain fatty acids and palmitate induce distinct metabolic and phenotypic signatures in normal and ischemic skeletal muscle microvascular endothelial cells. Cells 15(6), 493 (2026).

    7. Richieri, G.V., Anel, A., and Kleinfeld, A.M. Interactions of long-chain fatty acids and albumin: Determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 32(29), 7574-7580 (1993).